The Cytel Blog: Perspectives on Enquiry & Evidence

A combination of industry and policy forces have recently changed the shape of Australia’s R&D sector, making it a..

It is a common perception that the role of a Data Manager is only to perform what we call “Data Cleaning”; making sure..

Limited patient populations resulting in small study sample sizes is a difficulty associated with the development of..

While there is a plethora of rare diseases, some 7000 diseases and counting, one needs to consider the statutory..

A few weeks ago I wrote about new research conducted by Cytel statisticians, on the challenge of conducting..

The main challenge associated with the development of therapies for rare diseases is typically the small study sample..

In recent times, Single arm trials are being increasingly used to assess new treatment interventions. They establish..

Measuring treatment effect during a clinical trial is often the source of much debate, particularly during rare disease..

Cytel scientists recently published a new eBook on synthetic control arms and a new scientific primer for the more..